美國研究綜述-Adobe、Braveheart Bio、CACI International

路透中文

08/31

美國研究綜述-<a href="https://laohu8.com/S/ADBE">Adobe</a>、<a href="https://laohu8.com/S/BRVE">Braveheart Bio</a>、CACI International

路透8月31日 - 周一，華爾街證券分析師上調了包括Adobe、Braveheart Bio和CACI International在內的幾家美國上市公司的評級和目標股價。

重點摘要

* Adobe Inc ADBE.O：傑富瑞將目標價從230美元上調至285美元

* Braveheart Bio, Inc. BRVE.O：傑富瑞首次覆蓋該股，給予「買入」評級

* CACI International Inc CACI.N：TD Cowen將目標價從550美元上調至700美元

以下是路透周一報道的關於美國公司的研究動態摘要。股票條目按字母順序排列。

* Adobe Inc ADBE.O：傑富瑞將目標價從230美元上調至285美元

* ATI Inc ATI.N：TD Cowen將目標價從210美元上調至250美元

* Braveheart Bio Inc BRVE.O：傑富瑞首次覆蓋，給予「買入」評級

* Braveheart Bio Inc BRVE.O：傑富瑞（Jefferies）首次覆蓋，目標價48美元

* BRC Inc BRCC.N：D.A. Davidson 將目標價從 2.5 美元上調至 25 美元，以反映 1 股換 10 股的股票反向拆分

* CACI International Inc CACI.N：TD Cowen將目標價從550美元上調至700美元

* Dollar Tree Inc DLTR.O：Piper Sandler將目標價從114美元上調至121美元

* 霍尼韋爾航空航天公司 HONA.O：TD Cowen將目標價從250美元下調至180美元

* 洲際交易所（Intercontinental Exchange Inc） ICE.N：傑富瑞（Jefferies）將目標價從171美元上調至189美元

* Protagonist Therapeutics Inc PTGX.O：傑富瑞將目標價從169美元上調至171美元

* Rubrik Inc RBRK.N：加拿大帝國商業銀行（CIBC）將目標價從115美元上調至120美元

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/news/2663002003"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2663002003\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2663002003?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-08-31 15:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2663002003","market":"hk","top_or_hot":-1,"title":"美國研究綜述-Adobe、Braveheart Bio、CACI International","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>美國研究綜述-<a href=\"https://laohu8.com/S/ADBE\">Adobe</a>、<a href=\"https://laohu8.com/S/BRVE\">Braveheart Bio</a>、CACI International</title></head><body><p><span>路透8月31日</span><span> - </span>周一，華爾街證券分析師上調了包括Adobe、Braveheart Bio和CACI International在內的幾家美國上市公司的評級和目標股價。 </p><p>重點摘要</p><table><tbody><tr><td><p><span> * Adobe Inc <span>ADBE.O</span>：<a href=\"https://laohu8.com/S/JEF\">傑富瑞</a>將目標價從230美元上調至285美元</span></p></td></tr><tr><td><p><span> * Braveheart Bio, Inc. <span>BRVE.O</span>：傑富瑞首次覆蓋該股，給予「買入」評級</span></p></td></tr><tr><td><p><span> * CACI International Inc <span>CACI.N</span>：TD Cowen將目標價從550美元上調至700美元</span></p></td></tr></tbody></table><p>以下是路透周一報道的關於美國公司的研究動態摘要。股票條目按字母順序排列。 </p><table><tbody><tr><td><p><span> * Adobe Inc <span>ADBE.O</span>：傑富瑞將目標價從230美元上調至285美元</span></p></td></tr><tr><td><p><span> * ATI Inc <span>ATI.N</span>：TD Cowen將目標價從210美元上調至250美元</span></p></td></tr><tr><td><p><span> * Braveheart Bio Inc <span>BRVE.O</span>：傑富瑞首次覆蓋，給予「買入」評級</span></p></td></tr><tr><td><p><span> * Braveheart Bio Inc <span>BRVE.O</span>：傑富瑞（Jefferies）首次覆蓋，目標價48美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/BRCC\">BRC Inc</a> <span>BRCC.N</span>：D.A. Davidson 將目標價從 2.5 美元上調至 25 美元，以反映 1 股換 10 股的股票反向拆分</span></p></td></tr><tr><td><p><span> * CACI International Inc <span>CACI.N</span>：TD Cowen將目標價從550美元上調至700美元</span></p></td></tr><tr><td><p><span> * Dollar Tree Inc <span>DLTR.O</span>：Piper Sandler將目標價從114美元上調至121美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/HON\">霍尼韋爾</a>航空航天公司 <span>HONA.O</span>：TD Cowen將目標價從250美元下調至180美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/ICE\">洲際交易所</a>（Intercontinental Exchange Inc） <span>ICE.N</span>：傑富瑞（Jefferies）將目標價從171美元上調至189美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/PTGX\">Protagonist Therapeutics Inc</a> <span>PTGX.O</span>：傑富瑞將目標價從169美元上調至171美元</span></p></td></tr><tr><td><p><span> * Rubrik Inc <span>RBRK.N</span>：<a href=\"https://laohu8.com/S/CM\">加拿大帝國商業銀行</a>（CIBC）將目標價從115美元上調至120美元</span></p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美國研究綜述-Adobe、Braveheart Bio、CACI International</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美國研究綜述-Adobe、Braveheart Bio、CACI International\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time smaller\">2026-08-31 15:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>美國研究綜述-<a href=\"https://laohu8.com/S/ADBE\">Adobe</a>、<a href=\"https://laohu8.com/S/BRVE\">Braveheart Bio</a>、CACI International</title></head><body><p><span>路透8月31日</span><span> - </span>周一，華爾街證券分析師上調了包括Adobe、Braveheart Bio和CACI International在內的幾家美國上市公司的評級和目標股價。 </p><p>重點摘要</p><table><tbody><tr><td><p><span> * Adobe Inc <span>ADBE.O</span>：<a href=\"https://laohu8.com/S/JEF\">傑富瑞</a>將目標價從230美元上調至285美元</span></p></td></tr><tr><td><p><span> * Braveheart Bio, Inc. <span>BRVE.O</span>：傑富瑞首次覆蓋該股，給予「買入」評級</span></p></td></tr><tr><td><p><span> * CACI International Inc <span>CACI.N</span>：TD Cowen將目標價從550美元上調至700美元</span></p></td></tr></tbody></table><p>以下是路透周一報道的關於美國公司的研究動態摘要。股票條目按字母順序排列。 </p><table><tbody><tr><td><p><span> * Adobe Inc <span>ADBE.O</span>：傑富瑞將目標價從230美元上調至285美元</span></p></td></tr><tr><td><p><span> * ATI Inc <span>ATI.N</span>：TD Cowen將目標價從210美元上調至250美元</span></p></td></tr><tr><td><p><span> * Braveheart Bio Inc <span>BRVE.O</span>：傑富瑞首次覆蓋，給予「買入」評級</span></p></td></tr><tr><td><p><span> * Braveheart Bio Inc <span>BRVE.O</span>：傑富瑞（Jefferies）首次覆蓋，目標價48美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/BRCC\">BRC Inc</a> <span>BRCC.N</span>：D.A. Davidson 將目標價從 2.5 美元上調至 25 美元，以反映 1 股換 10 股的股票反向拆分</span></p></td></tr><tr><td><p><span> * CACI International Inc <span>CACI.N</span>：TD Cowen將目標價從550美元上調至700美元</span></p></td></tr><tr><td><p><span> * Dollar Tree Inc <span>DLTR.O</span>：Piper Sandler將目標價從114美元上調至121美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/HON\">霍尼韋爾</a>航空航天公司 <span>HONA.O</span>：TD Cowen將目標價從250美元下調至180美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/ICE\">洲際交易所</a>（Intercontinental Exchange Inc） <span>ICE.N</span>：傑富瑞（Jefferies）將目標價從171美元上調至189美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/PTGX\">Protagonist Therapeutics Inc</a> <span>PTGX.O</span>：傑富瑞將目標價從169美元上調至171美元</span></p></td></tr><tr><td><p><span> * Rubrik Inc <span>RBRK.N</span>：<a href=\"https://laohu8.com/S/CM\">加拿大帝國商業銀行</a>（CIBC）將目標價從115美元上調至120美元</span></p></td></tr></tbody></table></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4554","symbol_name":"元宇宙及AR概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4S44S0JC:1","article_id":"2663002003","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2663002003","pubTimestamp":1788161080,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"美國研究綜述-Adobe、Braveheart Bio、CACI International路透8月31日-周一，華爾街證券分析師上調了包括Adobe、Braveheart Bio和CACI International在內的幾家美國上市公司的評級和目標股價。重點摘要* Adobe IncADBE.O：傑富瑞將目標價從230美元上調至285美元* Braveheart Bio, Inc.BRVE.O：傑富瑞首次覆蓋該股，給予「買入」評級* CACI International IncCACI.N：TD Cowen將目標價從550美元上調至700美元以下是路透周一報道的關於美國公司的研究動態摘要。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4554":"元宇宙及AR概念","IE0031619046.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) INC","BCDF":"Horizon Kinetics Blockchain Development ETF","LU1035773651.USD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (USD) INC","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU1153585028.USD":"BGF GLOBAL LONG-HORIZON EQUITY  \"A4\" (USD) INC","BK4585":"ETF&股票定投概念","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU1823568750.SGD":"Fidelity Global Technology A-ACC SGD","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","SGXZ81514606.USD":"大华环球创新基金A Acc USD","LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU0157215616.USD":"FIDELITY GLOBAL FOCUS \"A\" INC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU0942090050.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD)  INC","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","LU0054578231.USD":"BGF SYSTEMATIC SUSTAINABLE GLOBAL SMALLCAP \"A2\" (USD) ACC","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","RBRK":"Rubrik Inc.","LU2286300806.USD":"Allianz Cyber Security AT Acc USD","LU1235294995.USD":"FIDELITY GLOBAL TECHNOLOGY \"A\" (USDHDG) ACC","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","PTGX":"Protagonist Therapeutics Inc","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","DLTR":"美元树公司","BK4550":"红杉资本持仓","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","BK4588":"碎股","LU0861579265.USD":"联博低波幅策略股票基金A","LU2458330169.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A\" (SGD) ACC","LU2247934214.USD":"FIDELITY FUNDS SUSTAINABLE FUTURE CONNECTIVITY \"A\" (USD) ACC","BRCC":"BRC Inc","LU0234572021.USD":"高盛美国核心股票组合Acc","LU2458330243.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A-H1\" (SGDHDG) ACC","LU0109392836.USD":"富兰克林科技股A","ADBU":"Direxion Daily ADBE Bull 2X ETF","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","BK4114":"综合货品商店","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","BK4155":"大卖场与超市","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","IE00B19Z4B17.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) ACC","PSWD":"XTRACKERS CYBERSECURITY SELECT EQUITY ETF","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU0061474960.USD":"天利环球焦点基金AU Acc","BK4567":"ESG概念","LU0683600562.USD":"AB SELECT US EQUITY \"A\" (USD) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","HON":"霍尼韦尔","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","ATI":"阿利根尼","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU0787776722.HKD":"AB SELECT US EQUITY PORTFOLIO \"A\" (HKD) ACC","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","BK4602":"量子计算概念","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","BK4006":"钢铁","BK4566":"资本集团","SGXZ99366536.SGD":"United Global Innovation A Acc SGD-H","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","BK4528":"SaaS概念","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4206":"工业集团企业","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0889565833.HKD":"FRANKLIN TECHNOLOGY \"A\" (HKD) ACC","LU0069063385.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (USD) ACC","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","BK4504":"桥水持仓","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","SPAM":"THEMES CYBERSECURITY ETF","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","BK4112":"金融交易所和数据","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","ADBE":"Adobe","LU0154245673.USD":"BNP PARIBAS US MID CAP \"C\" (USD) INC","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","BK4007":"制药","LU1633808545.USD":"ALLIANZ GLOBAL EQUITY GROWTH \"AT\" (USD) ACC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","LU0082616367.USD":"摩根大通美国科技A（dist）","BK4187":"航天航空与国防","BK4527":"明星科技股","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU1803068979.SGD":"FTIF - Franklin Technology A (acc) SGD-H1","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU1069347547.HKD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (HKD) INC","BK4123":"调查和咨询服务","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","LU1917777945.USD":"安联专题基金Cl AT Acc","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2317271919.USD":"BGF FUTURE CONSUMER \"A2\" (USD) ACC","LU0971096721.USD":"富达环球金融服务 A","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4613":"AI应用软件","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","LU0472753341.HKD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (HKD) ACC","BK4212":"包装食品与肉类","LU0057025933.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (USD) ACC","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","SG9999015978.USD":"利安颠覆性创新基金A","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU0345774391.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) ACC","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","CACI":"CACI国际","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BRVE":"Braveheart Bio","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU1046421795.USD":"富达环球科技A-ACC","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","IE00BQXX3F31.USD":"GUINNESS GLOBAL INNOVATORS \"C\" (USD) ACC","BK4097":"系统软件","LU2125154935.USD":"ALLSPRING (LUX) WF GLOBAL EQUITY ENHANCED INCOME \"I\" (USD) INC","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","IE00B66KJ199.SGD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY  \" A\" (SGD) ACC","BK4581":"高盛持仓","LU1366333091.USD":"FIDELITY GLOBAL FOCUS \"A\" (USD) ACC","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","BK4543":"AI","LU0557290698.USD":"施罗德环球可持续增长基金","BK4534":"瑞士信贷持仓","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","BK4139":"生物科技","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","LU0081259029.USD":"UBS (LUX) EQUITY FUND - TECH OPPORTUNITY \"P\" (USD) ACC","SG9999000418.SGD":"Aberdeen Standard Global Technology SGD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","HONG":"Leverage Shares 2X Long HON Daily ETF","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU0342679015.USD":"ALLIANZ GLOBAL EQUITY UNCONSTRAINED \"AT\" (USD) ACC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","BK4592":"伊斯兰概念","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0154245756.USD":"BNP PARIBAS US MID CAP \"C\" (USD) ACC","IE00B7SZL793.SGD":"Legg Mason Royce - US Small Cap Opportunity A Acc SGD-H","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","RSPS":"Invesco S&P 500 Equal Weight Consumer Staples ETF","SG9999001424.SGD":"United E-Commerce Fund SGD","LU1878469433.USD":"THREADNEEDLE (LUX) - AMERICAN SMALLER COMPANIES \"A\" (USD) ACC","ICE":"洲际交易所","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1261432733.SGD":"Fidelity World A-ACC-SGD","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","ADBG":"2倍做多ADBE ETF- Leverage Shares","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","BK4023":"应用软件"},"translate_title":"Review of American Studies - Adobe, Braveheart Bio, CACI International","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HON":1.84,"RBRK":1.84,"BRVE":1.94,"ATI":1.84,"ADBU":0.6,"RSPS":0.6,"PTGX":1.84,"CACI":1.94,"PSWD":0.6,"ADBG":0.6,"ICE":1.84,"BCDF":0.6,"DLTR":1.84,"HONG":0.6,"SPAM":0.6,"ADBE":1.94,"BRCC":1.84},"content_text":"美國研究綜述-<a href=\"https://laohu8.com/S/ADBE\">Adobe</a>、<a href=\"https://laohu8.com/S/BRVE\">Braveheart Bio</a>、CACI International路透8月31日 - 周一，華爾街證券分析師上調了包括Adobe、Braveheart Bio和CACI International在內的幾家美國上市公司的評級和目標股價。 重點摘要 * Adobe Inc ADBE.O：傑富瑞將目標價從230美元上調至285美元 * Braveheart Bio, Inc. BRVE.O：傑富瑞首次覆蓋該股，給予「買入」評級 * CACI International Inc CACI.N：TD Cowen將目標價從550美元上調至700美元以下是路透周一報道的關於美國公司的研究動態摘要。股票條目按字母順序排列。  * Adobe Inc ADBE.O：傑富瑞將目標價從230美元上調至285美元 * ATI Inc ATI.N：TD Cowen將目標價從210美元上調至250美元 * Braveheart Bio Inc BRVE.O：傑富瑞首次覆蓋，給予「買入」評級 * Braveheart Bio Inc BRVE.O：傑富瑞（Jefferies）首次覆蓋，目標價48美元 * BRC Inc BRCC.N：D.A. Davidson 將目標價從 2.5 美元上調至 25 美元，以反映 1 股換 10 股的股票反向拆分 * CACI International Inc CACI.N：TD Cowen將目標價從550美元上調至700美元 * Dollar Tree Inc DLTR.O：Piper Sandler將目標價從114美元上調至121美元 * 霍尼韋爾航空航天公司 HONA.O：TD Cowen將目標價從250美元下調至180美元 * 洲際交易所（Intercontinental Exchange Inc） ICE.N：傑富瑞（Jefferies）將目標價從171美元上調至189美元 * Protagonist Therapeutics Inc PTGX.O：傑富瑞將目標價從169美元上調至171美元 * Rubrik Inc RBRK.N：加拿大帝國商業銀行（CIBC）將目標價從115美元上調至120美元","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}